Programmed cell death 2 protein induces gastric cancer cell growth arrest at the early S phase of the cell cycle and apoptosis in a p53-dependent manner

Oncology Reports

Volumn 33, Issue 1, 2015, Pages 103-110

  Zhang, Jian ^a   Wei, Wei ^a   Jin, Hui Cheng ^a   Ying, Rong Chao ^a   Zhu, A Kao ^a   Zhang, Fang Jie ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Cell cycle; Gastric cancer; P53; PDCD2

Indexed keywords

ATM PROTEIN; CHECKPOINT KINASE 1; NUCLEAR PROTEIN; PROGRAMMED CELL DEATH 2 RECEPTOR; PROTEIN P53; UNCLASSIFIED DRUG; APOPTOSIS REGULATORY PROTEIN; PDCD2 PROTEIN, HUMAN; TP53 PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CANCER SURVIVAL; CELL CYCLE S PHASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME INHIBITION; FEMALE; GASTRIC CANCER CELL LINE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MALE; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SKIN CARCINOGENESIS; STOMACH CANCER; ULTRAVIOLET B RADIATION; WESTERN BLOTTING; ANIMAL; C57BL MOUSE; KAPLAN MEIER METHOD; KNOCKOUT MOUSE; METABOLISM; MORTALITY; NUDE MOUSE; PATHOLOGY; PHYSIOLOGY; S PHASE CELL CYCLE CHECKPOINT; SKIN TUMOR; STOMACH TUMOR; TUMOR CELL LINE;

ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CELL LINE, TUMOR; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, NUDE; S PHASE CELL CYCLE CHECKPOINTS; SIGNAL TRANSDUCTION; SKIN NEOPLASMS; STOMACH NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84916199350     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2014.3551     Document Type: Article

References (28)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin 61: 69-90, 2011.
2. Tahara E: Genetic pathways of two types of gastric cancer. IARC Sci Publ 157: 327-349, 2004.
3. Owens GP, Hahn WE and Cohen JJ: Identification of mRNAs associated with programmed cell death in immature thymocytes. Mol Cell Biol 11: 4177-4188, 1991.
4. Kawakami T, Furukawa Y, Sudo K, et al: Isolation and mapping of a human gene (PDCD2) that is highly homologous to Rp8, a rat gene associated with programmed cell death. Cytogenet Cell Genet 71: 41-43, 1995.
5. Merup M, Moreno TC, Heyman M, et al: 6q deletions in acute lymphoblastic leukemia and non-Hodgkin's lymphomas. Blood 91: 3397-3400, 1998.
6. Minakhina S, Druzhinina M and Steward R: Zfrp8, the Drosophila ortholog of PDCD2, functions in lymph gland development and controls cell proliferation. Development 134: 2387-2396, 2007.
7. Mu W, Munroe RJ, Barker AK and Schimenti JC: PDCD2 is essential for inner cell mass development and embryonic stem cell maintenance. Dev Biol 347: 279-288, 2010.
8. Ramalho-Santos M, Yoon S, Matsuzaki Y, Mulligan RC and Melton DA: 'Stemness': transcriptional profiling of embryonic and adult stem cells. Science 298: 597-600, 2002.
9. Skottman H, Mikkola M, Lundin K, et al: Gene expression signatures of seven individual human embryonic stem cell lines. Stem Cells 23: 1343-1356, 2005.
10. Fan CW, Chan CC, Chao CC, Fan HA, Sheu DL and Chan EC: Expression patterns of cell cycle and apoptosis-related genes in a multidrug-resistant human colon carcinoma cell line. Scand J Gastroenterol 39: 464-469, 2004.
11. Lou Y, Peng Q, Nolan B, Wagner GC and Lu Y: Oral administration of caffeine during voluntary exercise markedly decreases tissue fat and stimulates apoptosis and cyclin B1 in UVB-treated skin of hairless p53-knockout mice. Carcinogenesis 31: 671-678, 2010.
12. Baron BW, Hyjek E, Gladstone B, Thirman MJ and Baron JM: PDCD2, a protein whose expression is repressed by BCL6, induces apoptosis in human cells by activation of the caspase cascade. Blood Cells Mol Dis 45: 169-175, 2010.
13. Barboza N, Minakhina S, Medina DJ, et al: PDCD2 functions in cancer cell proliferation and predicts relapsed leukemia. Cancer Biol Ther 14: 546-555, 2013.
14. Andreotti V, Ciribilli Y, Monti P, et al: p53 transactivation and the impact of mutations, cofactors and small molecules using a simplified yeast-based screening system. PLoS One 6: e20643, 2011.
15. Yellapa A, Bitterman P, Sharma S, et al: Interleukin 16 expression changes in association with ovarian malignant transformation. Am J Obstet Gynecol 210: 272.e1-10, 2014.
16. Everett SM, White KL, Drake IM, et al: The effect of Helicobacter pylori infection on levels of DNA damage in gastric epithelial cells. Helicobacter 7: 271-280, 2002.
17. Canzian F, Franceschi S, Plummer M, et al: Genetic polymorphisms in mediators of inflammation and gastric precancerous lesions. Eur J Cancer Prev 17: 178-183, 2008.
18. Lazər D, Təban S, Sporea I, et al: The immunohistochemical expression of the p53-protein in gastric carcinomas. Correlation with clinicopathological factors and survival of patients. Rom J Morphol Embryol 51: 249-257, 2010.
19. Liu X, Wang S, Xia X, et al: Synergistic role between p53 and JWA: prognostic and predictive biomarkers in gastric cancer. PLoS One 7: e52348, 2012.
20. Harrison JC and Haber JE: Surviving the breakup: the DNA damage checkpoint. Annu Rev Genet 40: 209-235, 2006.
21. Sancar A, Lindsey-Boltz LA, Unsal-Kaçmaz K and Linn S: Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu Rev Biochem 73: 39-85, 2004.
22. van Jaarsveld MT, Wouters MD, Boersma AW, et al: DNA damage responsive microRNAs misexpressed in human cancer modulate therapy sensitivity. Mol Oncol 8: 458-468, 2014.
23. Smith GC, Cary RB, Lakin ND, et al: Purification and DNA binding properties of the ataxia-telangiectasia gene product ATM. Proc Natl Acad Sci USA 96: 11134-11139, 1999.
24. Stracker TH, Usui T and Petrini JH: Taking the time to make important decisions: the checkpoint effector kinases Chk1 and Chk2 and the DNA damage response. DNA Repair (Amst) 8: 1047-1054, 2009.
25. Sun X, Liu B, Wang J, Li J and Ji WY: Inhibition of p21-activated kinase 4 expression suppresses the proliferation of Hep-2 laryngeal carcinoma cells via activation of the ATM/Chk1/2/p53 pathway. Int J Oncol 42: 683-689, 2013.
26. Kokorina NA, Granier CJ, Zakharkin SO, Davis S, Rabson AB and Sabaawy HE: PDCD2 knockdown inhibits erythroid but not megakaryocytic lineage differentiation of human hematopoietic stem/progenitor cells. Exp Hematol 40: 1028-1042.e3, 2012.
27. Kramer J, Granier CJ, Davis S, et al: PDCD2 controls hematopoietic stem cell differentiation during development. Stem Cells Dev 22: 58-72, 2013.
28. Scarr RB and Sharp PA: PDCD2 is a negative regulator of HCF-1 (C1). Oncogene 21: 5245-5254, 2002.